Merck's Patent On Blockbuster Osteoporosis Drug Fosamax Runs Out - Trading Markets (press release)
... Fosamax has run out and faces its next big patent expiration in 2010, when the $3 billion-a-year Cozaar/Hyzaar hypertension franchise loses protection. ...